BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36598455)

  • 1. Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
    Obiorah IE; Karrs J; Brown L; Wang HW; Karai LJ; Pham TH; Pham TA; Xi L; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2023 Mar; 47(3):344-353. PubMed ID: 36598455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder or Primary Cutaneous Marginal Zone B-Cell Lymphoma? Two Distinct Entities With Overlapping Histopathological Features.
    Bakr F; Wain EM; Barlow R; Robson A
    Am J Dermatopathol; 2021 Dec; 43(12):e204-e212. PubMed ID: 34231494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How I Diagnose Primary Cutaneous Marginal Zone Lymphoma.
    Gibson SE; Swerdlow SH
    Am J Clin Pathol; 2020 Sep; 154(4):428-449. PubMed ID: 32808967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class-switched Primary Cutaneous Marginal Zone Lymphomas Are Frequently IgG4-positive and Have Features Distinct From IgM-positive Cases.
    Carlsen ED; Swerdlow SH; Cook JR; Gibson SE
    Am J Surg Pathol; 2019 Oct; 43(10):1403-1412. PubMed ID: 31464711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous lymphoproliferative disorders: Back to the future.
    Willemze R
    J Cutan Pathol; 2024 Jun; 51(6):468-476. PubMed ID: 38499969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous involvement with marginal zone lymphoma.
    Gerami P; Wickless SC; Querfeld C; Rosen ST; Kuzel TM; Guitart J
    J Am Acad Dermatol; 2010 Jul; 63(1):142-5. PubMed ID: 20462658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior.
    Grogg KL; Jung S; Erickson LA; McClure RF; Dogan A
    Mod Pathol; 2008 Jun; 21(6):708-15. PubMed ID: 18311111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG4 Expression in Primary Cutaneous Marginal Zone Lymphoma: A Multicenter Study.
    De Souza A; Ferry JA; Burghart DR; Tinguely M; Goyal A; Duncan LM; Kutzner H; Kempf W
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):462-467. PubMed ID: 28151793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD123-positive plasmacytoid dendritic cells in primary cutaneous marginal zone B-cell lymphoma: diagnostic and pathogenetic implications.
    Kutzner H; Kerl H; Pfaltz MC; Kempf W
    Am J Surg Pathol; 2009 Sep; 33(9):1307-13. PubMed ID: 19718787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous blastic marginal zone lymphoma: A comprehensive clinical, light microscopic, phenotypic and cytogenetic appraisal.
    Magro CM; Kalomeris T; Roberts A
    Ann Diagn Pathol; 2023 Apr; 63():152101. PubMed ID: 36634549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous marginal zone B-cell lymphoma with amyloid deposition: report of two cases with review of literature.
    Zhang HY; Liu AL; Zhou LS; He MX; Wang JX
    Chin J Cancer; 2010 Jun; 29(6):634-40. PubMed ID: 20507739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder-clinical and histopathologic features, differential diagnosis, and treatment.
    Gru AA; Wick MR; Eid M
    Semin Cutan Med Surg; 2018 Mar; 37(1):39-48. PubMed ID: 29719019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous marginal zone lymphoma in children: a report of 3 cases and review of the literature.
    Kempf W; Kazakov DV; Buechner SA; Graf M; Zettl A; Zimmermann DR; Tinguely M
    Am J Dermatopathol; 2014 Aug; 36(8):661-6. PubMed ID: 24698939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
    Magro CM; Olson LC; Fulmer CG
    Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies and considerations in the diagnosis of primary cutaneous CD4⁺ small/medium T-cell lymphoma.
    Lan TT; Brown NA; Hristov AC
    Arch Pathol Lab Med; 2014 Oct; 138(10):1307-18. PubMed ID: 25268194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review.
    Salah E
    J Dtsch Dermatol Ges; 2019 Feb; 17(2):123-136. PubMed ID: 30506921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up and management of small and medium-sized CD4
    Virmani P; Jawed S; Myskowski PL; Horwitz S; Skripnik Lucas A; Moskowitz A; Pulitzer M; Zain J; Rosen ST; Querfeld C
    Int J Dermatol; 2016 Nov; 55(11):1248-1254. PubMed ID: 27369070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent immunoglobulin G4 expression in a common variant of primary cutaneous marginal zone B-cell lymphoma.
    Sun JR; Nong L; Liu XQ; Tu P; Wang Y
    Australas J Dermatol; 2018 May; 59(2):141-145. PubMed ID: 28980311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic features of primary mucosal CD30-positive T-cell lymphoproliferative disorders in head and neck region].
    Liu F; Li M; Zhang LY; Guo L; Hu WW; Rao HL
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):412-416. PubMed ID: 29886583
    [No Abstract]   [Full Text] [Related]  

  • 20. Symmetrical primary cutaneous marginal zone lymphoma associated with rheumatoid arthritis.
    Yildirim FE; Karaduman A; Hürmüz P; Ozyar E; Barişta I; Sağlam A
    J Cutan Pathol; 2010 May; 37(5):600-4. PubMed ID: 19674036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.